512036 — Skybiotech Healthcare Balance Sheet
0.000.00%
- IN₹331.20m
- IN₹433.89m
- IN₹70.98m
Annual balance sheet for Skybiotech Healthcare, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | — | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 0.117 | 0.175 | 84.3 | -2.69 | -5.94 |
| Net Total Receivables | 0.042 | 0.032 | 0 | 4.32 | 11.2 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 0.159 | 0.207 | 86 | 19.2 | 13.3 |
| Net Property, Plant And Equipment | 0.07 | 0.055 | 0.048 | 88.5 | 83.7 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 43.7 | 40.6 | 115 | 201 | 194 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.083 | 0.072 | 4.07 | 25.5 | 19.4 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 6.52 | 5.72 | 6.94 | 111 | 114 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 37.2 | 34.9 | 108 | 89.9 | 79.9 |
| Total Liabilities & Shareholders' Equity | 43.7 | 40.6 | 115 | 201 | 194 |
| Total Common Shares Outstanding |